 | | Rilpivirine (Edurant, TMC 278) |  | | Published
June 20, 2011; Updated
March 2013 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-02-05 | | | Selected Reference | | 4. | Pozniak AL, Morales-Ramirez J, Katabira E, et al; TMC278-C204 Study Group. Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial. AIDS. 2010 Jan 2;24(1):55-65. | |
|
|
|
